Tracleer, dispergierbare Tabletten - 56 Tablette(n) Swissmedic Key 59885001 Registration Holder Janssen-Cilag AG Name Tracleer, dispergierbare Tabletten Date of registration 21.07.2010 Introduction of Sequence 21.07.2010 ATC-Classification Bosentan (C02KX01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 56 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680598850015 Medication Code Synthetika Pharmacode Disponibility
Composition bosentanum 32 mg ut bosentanum monohydricum, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium 0.812 mg, silica colloidalis anhydrica, acidum tartaricum, aspartamum 3.7 mg, aromatica (Tutti Frutti) cum alcohol benzylicus 0.36 mg, acesulfamum kalicum, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Dispersible Tablets Active Agent Dose Bosentan 32 mg
Inactive agents Dose Acesulfamum Kalicum Tartaric Acid Aromatica (Tutti Frutti) cum Alcohol Benzylicus 0.36 mg Aspartame 3.7 mg Calcium Hydrogen Phosphate Carmellosum Natricum Conexum Cellulosum Microcristallinum Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
